Claus Christiansen Selected Research

salmon calcitonin (Calcimar)

10/2016	A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.
8/2014	Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats.
7/2013	Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in rats.
11/2010	Oral salmon calcitonin--pharmacology in osteoporosis.
9/2005	Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claus Christiansen Research Topics

Disease

23	Osteoporosis 02/2017 - 12/2003
21	Bone Resorption 12/2021 - 01/2003
13	Osteoarthritis 01/2018 - 09/2004
12	Postmenopausal Osteoporosis 10/2016 - 02/2004
8	Neoplasms (Cancer) 03/2022 - 12/2006
8	Insulin Resistance 12/2021 - 10/2004
8	Type 2 Diabetes Mellitus (MODY) 01/2017 - 03/2006
8	Atherosclerosis 02/2014 - 07/2003
7	Cognitive Dysfunction 10/2020 - 09/2004
7	Osteoporotic Fractures 08/2016 - 04/2004
6	Fibrosis (Cirrhosis) 03/2022 - 10/2010
6	Knee Osteoarthritis 01/2021 - 10/2004
5	Obesity 12/2021 - 10/2004
5	Rheumatoid Arthritis 01/2021 - 04/2011
5	Liver Cirrhosis (Hepatic Cirrhosis) 12/2016 - 10/2010
5	Breast Neoplasms (Breast Cancer) 02/2011 - 10/2002
4	Inflammation (Inflammations) 01/2021 - 01/2013
4	Dementia (Dementias) 10/2020 - 03/2016
4	Pain (Aches) 01/2019 - 02/2013
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2013 - 04/2005
3	Weight Loss (Weight Reduction) 12/2021 - 07/2014
3	Bone Diseases (Bone Disease) 01/2015 - 01/2003
2	Chronic Disease (Chronic Diseases) 06/2021 - 02/2014
2	Hyperlipidemias (Hyperlipidemia) 10/2020 - 10/2004
2	Myocardial Infarction 01/2018 - 07/2012
2	Weight Gain 01/2017 - 05/2011
2	Hepatitis C 12/2016 - 01/2012
2	Hip Fractures (Intertrochanteric Fractures) 01/2015 - 08/2009
2	Osteopetrosis 01/2015 - 04/2007
2	Prostatic Neoplasms (Prostate Cancer) 10/2014 - 06/2008
2	Body Weight (Weight, Body) 08/2014 - 07/2013
2	Hyperglycemia 07/2014 - 12/2011
2	Disease Progression 08/2013 - 12/2006
2	Rheumatic Diseases (Rheumatism) 04/2013 - 04/2011
2	Ankylosing Spondylitis 04/2013 - 01/2013
2	Joint Diseases (Joint Disease) 12/2011 - 09/2004
2	Muscle Cramp (Cramp) 06/2010 - 12/2008
2	Hyperplasia 04/2010 - 10/2002
2	Coronary Disease (Coronary Heart Disease) 11/2009 - 04/2003
2	Osteonecrosis (Kienbock's Disease) 08/2009 - 01/2006
2	Neoplasm Metastasis (Metastasis) 12/2006 - 01/2003

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2004
16	Collagen Type I (Type I Collagen)IBA 10/2020 - 01/2003
10	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 04/2003
10	Estrogens (Estrogen)FDA Link 05/2013 - 02/2004
9	Insulin (Novolin)FDA Link 01/2017 - 06/2007
7	Hormones (Hormone)IBA 06/2021 - 12/2003
7	Matrix Metalloproteinases (MMPs)IBA 10/2020 - 01/2012
6	Pharmaceutical PreparationsIBA 03/2022 - 07/2008
6	Proteins (Proteins, Gene)FDA Link 10/2014 - 04/2007
6	Raloxifene Hydrochloride (Evista)FDA Link 02/2014 - 04/2008
6	Selective Estrogen Receptor Modulators (SERM)IBA 02/2011 - 09/2004
5	OsteocalcinIBA 10/2019 - 02/2004
5	VimentinIBA 08/2017 - 01/2012
5	salmon calcitonin (Calcimar)FDA LinkGeneric 10/2016 - 09/2005
5	Diphosphonates (Bisphosphonates)IBA 09/2008 - 08/2004
4	Collagen Type III (Type III Collagen)IBA 03/2022 - 10/2010
4	CollagenIBA 10/2020 - 02/2008
4	LipidsIBA 12/2016 - 04/2003
4	strontium ranelate (protelos)IBA 02/2013 - 01/2007
4	EpitopesIBA 01/2013 - 01/2003
3	Peptides (Polypeptides)IBA 03/2022 - 11/2010
3	Apolipoproteins E (ApoE)IBA 10/2020 - 06/2006
3	balaglitazoneIBA 01/2017 - 05/2011
3	PPAR gammaIBA 01/2017 - 12/2005
3	CalciumIBA 10/2016 - 07/2012
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2016 - 01/2006
3	Denosumab FDA Link 02/2014 - 08/2009
3	Monoclonal AntibodiesIBA 02/2014 - 08/2009
3	Peptide Hydrolases (Proteases)FDA Link 08/2013 - 04/2010
3	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2013 - 01/2012
3	EnzymesIBA 03/2013 - 09/2008
3	Collagen Type II (Type II Collagen)IBA 01/2013 - 10/2004
3	bazedoxifeneIBA 06/2010 - 04/2008
3	Cathepsin KIBA 04/2010 - 02/2005
3	Ibandronic Acid (Boniva)FDA Link 06/2006 - 08/2004
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2021 - 07/2014
2	KBP-042IBA 12/2021 - 07/2014
2	endotrophinIBA 06/2021 - 01/2017
2	C-Reactive ProteinIBA 01/2021 - 08/2013
2	catch-relaxing peptide (Mytilus)IBA 01/2021 - 02/2014
2	Collagen Type IV (Type IV Collagen)IBA 08/2017 - 01/2016
2	abaloparatideIBA 02/2017 - 08/2016
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 02/2017 - 10/2004
2	Pioglitazone (Actos)FDA Link 01/2017 - 05/2011
2	Complement C3 (C3 Complement)IBA 12/2016 - 01/2013
2	Alanine Transaminase (SGPT)IBA 12/2016 - 03/2013
2	Biological ProductsIBA 01/2016 - 12/2011
2	Indicators and Reagents (Reagents)IBA 02/2014 - 04/2005
2	CytokinesIBA 08/2013 - 05/2013
2	AdipokinesIBA 05/2013 - 10/2004
2	ImmunosorbentsIBA 03/2013 - 10/2010
2	Estradiol (Delestrogen)FDA LinkGeneric 07/2009 - 10/2004
2	Transcription Factors (Transcription Factor)IBA 06/2007 - 03/2006
2	AdiponectinIBA 12/2005 - 10/2004
2	Progestins (Progestagens)IBA 05/2004 - 10/2002

Therapy/Procedure

14	Therapeutics 01/2017 - 01/2004
4	Hormone Replacement Therapy (Therapy, Hormone Replacement) 11/2009 - 10/2002
3	Fracture Fixation 01/2015 - 03/2011
2	Injections 03/2011 - 06/2006